Oramed Pharmaceuticals Inc.ORMPNASDAQ
LOADING
|||
| Metric | Aug 20 | Aug 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 3 | 3↓0.3% | 3↓0.0% | 1↓50.4% | 0 |
| Gross Profit | 3 | 3↑3.2% | 3↓0.0% | 1↓50.4% | -0↓114.4% |
| Operating Income | -12 | -24↓106.0% | -41↓67.6% | -16↑61.2% | -13↑18.9% |
| Net Income | -12 | -22↓93.2% | -38↓69.8% | 6↑114.6% | -19↓445.8% |
| EBITDA | -11 | -25↓121.3% | -37↓47.7% | 7↑119.8% | -15↓303.2% |
| EPS Diluted | -0.56 | -0.78↓39.3% | -0.97↓24.4% | 0.14↑114.4% | -0.47↓435.7% |